Upload
wghns001
View
639
Download
0
Tags:
Embed Size (px)
Citation preview
Binax NOW RTI Products
1
2WHO comments:
More than any other infectious disease, pneumonia remains the number one killer worldwide.
Streptococcus pneumoniae and Haemophilus influenzaeare the top two bacterial causes of acute respiratory infections.
Both viral and bacteria respiratory infections present the same clinical symptoms and can often only be distinguished by laboratory tests
80% of pneumonia patients may unnecessarily be given antibiotics - contributing to antibiotic resistance
2
3Case Review Respiratory Tract Infection (RTI) cases
very large cases several diseases with similar symptoms
Target cases Community-acquired pneumonia Nosocomial pneumonia cases Acute Flu-like cases
3
4Community - Acquired Pneumonia
~12 million cases treated annually worldwide
S. pneumoniae is the leading cause ofbacterial pneumonia -up to 65% of cases in some studies
Legionella also a leading cause of community-acquired pneumonia - up to 15%
S. pneumoniae and Legionella pneumonia have high mortality rates - as high as 30%
4
5Acute Flu-like Cases Clinical symptoms of lower RTI diseases
(pneumonia, acute influenza and acute bronchitis) similar
Bacterial pneumonia can be a complication of acute influenza or acute bronchitis
Significantly increases overall case potential
5
6Disease Overview
6
7Causative Agents of Community-Acquired Pneumonia
Bacterial Viral
Streptococcus pneumoniae Influenza A & B
Legionella pneumohila RSV
Haemophilus influenza type B Adenovirus
Non typable Haemophilus Para Influenza
Staphlococcus aureus
Moraxella catarrhalis
Pseudomonas aeruginosa
Chlymydia pneumonia
Mycoplasma pneumonia 7
8Community-Acquired PneumoniaCAP
S. pneumoniae is the leading cause of bacterial pneumonia and CAP - up to 65% of all cases in some studies
Legionella also a leading cause of community-acquired pneumonia - up to 15%
S. pneumoniae and Legionella pneumonia have high mortality rates - as high as 30%
Bacterial infections can occur as a complication of influenza
8
9Community-Acquired Pneumonia
Transmission: person to person by direct contact with infectious secretions
Risk groups elderly children under 2 and /
or attending day care patients with
underlying illness immunocompromised
patients
Symptoms fever, chills chest pain, pleurisy,
difficulty breathing blood-tinged sputum headache cough (often non-
productive)
9
10
Community-Acquired Pneumonia
Treatment Pathogen-specific diagnosis -
help direct the most cost-effective treatment minimizes the risk of increasing antibiotic resistance
Empirical treatment may not always be the most cost-effective treatment increases the risk of antibiotic resistance
10
11
Community-Acquired Pneumonia
many strains of S. pneumoniae have intermediate sensitivity and resistance to penicillin and resistance to single or multiple broad-spectrum antibiotics (Goldstein and Acar, 1996)
accurate diagnosis required allowing specificantibiotic therapy
11
12
Diagnostics
12
13
Diagnostics
Blood Culture
Sputum Culture
Sputum Gram Stain
PCR / DFA
NOW ICT Urinary Antigen Test
13
14
Diagnostics Blood Culture
Advantages positive = confirmation patient is bacteremic allows for drug susceptibility testing
Disadvantages only 10-30% of all pneumonia cases are
bacteremic - positive culture result in only 25% of cases (Musher, 1992)
potential errors by technician
14
15
Diagnostics Blood Culture
Disadvantages can also be positive in patients with meningitis,
otitis media, septic arthritis, etc 24-48 hours incubation requires experienced technicians to perform and
interpret results expensive
technician time instrumentation (incubators)
invasive for the patient
15
16
Diagnostics Sputum Culture
Advantages supplies and reagents relatively inexpensive non-invasive for the patient allows for drug susceptibility testing
Disadvantages samples must be taken prior to antibiotic therapy sample required from lower respiratory tract;
difficult to obtain (non-productive cough, children, elderly)
16
17
Diagnostics Sputum Culture
Disadvantages samples must be processed immediately
delays reduce isolation rates of the organism high false positive rates (carrier) low sensitivity and specificity
normally 48 hours for positive identification
17
18
Diagnostics Sputum Culture
Disadvantages expensive
technician time equipment experienced personnel are needed to perform and
interpret results
Difficult to identify infecting organism
18
19
Diagnostics Sputum Gram Stain
Advantages inexpensive reagents and supplies non-invasive for the patient rapid test time
Disadvantages requires sample from lower respiratory tract;
difficult to obtain samples must be processed immediately
19
20
Diagnostics Sputum Gram Stain
Disadvantages high false positive rate low sensitivity and specificity; large numbers of
organisms must be present does not allow for drug susceptibility testing requires experienced personnel
20
21
Diagnostics PCR / DFA
Advantages same day results specificity
Disadvantages requires sample from lower respiratory tract;
difficult to obtain expensive - equipment, skilled technician sensitivity
21
22
Diagnostics NOW ICT Urinary Antigen
Technology detects antigen, which is a common component of
the cell wall within the species S. pneumoniae - C-polysaccharide antigen, common to
all serotypes within the species Legionella - lipopolysaccharide portion of the serogroup
1 cell wall rabbit anti-species antibody as capture component rabbit anti-species antibody conjugated to colloidal
gold as detection component
22
23
Technology
Absorbent Control Line--Goat
anti-rabbit IgG Sample Line--Rabbit
anti-S. pneumoniaeantibody
Conjugate Pad Sample Pad ( patent No. 91/214051).
23
24
Intellectual Property 12 Issued Patents
4 ICT platform 7 Magnetic particles 1 Meningitis test
11 Patents Applied For respiratory, meningitis, and bacteria screen area
24
25
Diagnostics NOW ICT Urinary Antigen
Advantages rapid results - 15 minutes non-invasive sample - urine easy test to run and interpret results accurate
Limitations Susceptibility cannot be performed Single bacteria test
25
2626
27
Diagnostics NOW ICT Urinary Antigen
Performance Data S. pneumoniae
Sensitivity 86% Specificity 94%
Legionella Sensitivity 95% Specificity 95%
27
28
Comparison of Streptococcus pneumoniae Test Methods
Methods Sample Type Sensitivity Specificity Time
Binax NOW Urine 86%1 94% 1 15 mins
PCR Blood 52% 100% 4 hrs
Blood Culture Blood 10-30% 2 >95% 48 hrs
Sputum Culture Sputum 50-60% 50-80% 48 hrs
Sputum Gram Stain Sputum 50-60% 50-80% 15 mins
Diagnostics
1-Retrospective study data -- blood culture used as reference method.2-Numbers reflect percent of pneumonia patient population estimated to be bacteremic.
Note: Sensitivity and specificity data on blood culture, sputum culture, and sputum Gram stain taken from variouspublished studies. References available upon request.
28
29
NOW ICT Features Easy to run Rapid test - only 15 minute tests for
S. pneumoniae and Legionella available Uses non-invasive sample No special equipment needed Easy to interpret resul
Positioning
29
30
Accurate results U.S. FDA cleared products Multiple applications for S. pneumoniae
test - pneumonia, CSF and otitis media
30
31
NOW ICT S. pneumoniaeadditional applications
31
32
CSF application
Anti-microbial therapy often initiated empirically because causative agent not identified in advance
Sensitivity of CSF gram staining is 75% - decreases to 50% in patients given anti-microbial therapy
Latex bacterial antigen assays have low sensitivity in CSF Streptococcus pneumoniae is typically the second most
common causative agent of community-acquired acute bacterial meningitis
Increasing rates of pneumococcal resistance to penicillin and third generation cephalosporins
32
33
CSF application
NOW ICT S. pneumoniae test 100% sensitivity and specificity with CSF sample published studies
New Rapid Antigen Test for Diagnosis of PneumococcalMeningitis.Marcos et al, The Lancet 357: 1499-1500, 2001.
Using the NOW test in Cerebrospinal Fluid for the Rapid Diagnosis of Pneumococcal meningitis.Samrai et al, ASM: 114, 2001.
33
34
CSF application
NOW ICT S. pneumoniae test additional application to support bringing the test into a
hospital lab only accurate rapid test for detection of a critical
pathogen for bacterial meningitis
34
35
Otitis Media application
NOW ICT S. pneumoniae test Rapid Detection of S. pneumoniae in the Airways of Children
with Acute Otitis Media.Faden et al, ASM: 113, 2001.
Sensitivity 90.0% (18/20) versus culture positive nasopharangeal samples
Specificity 86.9% (21/23) versus culture negative nasopharangeal samples
one of three leading causes of otitis media
35
36
Published Studies - S. pneumoniae Evaluation of a Rapid Immunochromatographic Test for the
Detection of Streptococcus pneumoniae Antigen in Urine Samples from Adults with Community-Acquired Pneumonia
Murdoch et al, ASM: 112, 2001 Detection of Streptococcus pneumoniae Antigen by a Rapid
Immunochromatographic Assay in Urine Specimens Dominguez et al: Chest, 119: 243-249, 2001
Diagnostic Utility of a Rapid Urine Pneumococcal Antigen Assay
Neuman et al, 2001 Pediatric Academic Societies Meeting
Reference
36
37
Published Studies - S. pneumoniae Evaluation of Binax NOW, an Assay for the Detection of
Pneumococcal Antigen in Urine Samples, Performed among Pediatric Patients
Dowell et al, Clinical Infectious Diseases, 32: 2001 New Rapid Test for Detecting S. pneumoniae in Lower
Respiratory Tract InfectionsLienhard et al, Clinical Microbiology and Infection 7: 101
37
38
Detection of Streptococcus pneumoniae Antigen by a Rapid Immunochromatogrphic Assay in Urine Samples
CHEST, 119: 243-249, 2001J.Dominguez et al
Detection of Streptococcus pneumoniae Antigen by a Rapid Immunochromatogrphic Assay in Urine Samples
CHEST, 119: 243-249, 2001J.Dominguez et al
Conclusions(1) Now S. pneumoniae test is sensitive and specific(2) Now S. pneumoniae test is a valuable tool for diagnosing
pneumococcal pneumonia cases, especially nonbacteremic cases, which are often not diagnosed.
(3) Blood culture is only useful in approximately 25% of pneumococcal pneumonia cases (i.e. that is the percent of the population that is bacteremic).
(4) Sputum cultures only provide a probable diagnosis due to difficulties associated with methodology (obtaining reliable samples, etc.) and samples for culture are rarely taken invasively due to concerns with the techniques that must be used.
38
39
Evaluation of a Rapid Immunochromatographic Test for the Detection of Streptococcus pneumoniae Antigen
in Urine Samples from Adults with Community-Acquired Pneumonia
ASM: 112, 2001 Murdoch et al,
Evaluation of a Rapid Immunochromatographic Test for the Detection of Streptococcus pneumoniae Antigen
in Urine Samples from Adults with Community-Acquired Pneumonia
ASM: 112, 2001 Murdoch et al,
The authors conclude : The Now S. pneumoniae antigen test is a useful
adjunct to culture for determining the etiology of community-acquired pneumonia in adults.
39
4040
4141
90.01.05
Immuno-Chromatographic Test v.s. Latex Agglutination Test
108 CFU/ml* Positive 108 CFU/ml Positive
107 CFU/ml Positive 107 CFU/ml Negative
106 CFU/ml Positive 106 CFU/ml Negative
105 CFU/ml Positive (weak) 105 CFU/ml Negative
104 CFU/ml Negative 104 CFU/ml Negative
Now Wellcogen
* Adjust cell suspension of S. pneumoniae to 0.5 McFarland ( 108 CFU/ml )
Binax NOW RTI ProductsCase ReviewCommunity - Acquired PneumoniaAcute Flu-like CasesDisease OverviewCausative Agents of Community-Acquired PneumoniaCommunity-Acquired PneumoniaCAPCommunity-Acquired PneumoniaCommunity-Acquired PneumoniaCommunity-Acquired PneumoniaDiagnosticsDiagnosticsDiagnosticsDiagnosticsDiagnosticsDiagnosticsDiagnosticsDiagnosticsDiagnosticsDiagnosticsDiagnosticsTechnologyIntellectual PropertyDiagnosticsDiagnosticsComparison of Streptococcus pneumoniae Test MethodsPositioningNOW ICT S. pneumoniae additional applicationsCSF applicationCSF applicationCSF applicationOtitis Media application